<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04182503</url>
  </required_header>
  <id_info>
    <org_study_id>2018YFC1004300</org_study_id>
    <nct_id>NCT04182503</nct_id>
  </id_info>
  <brief_title>Environmental Factors and Embryonic Development Project</brief_title>
  <acronym>EFED</acronym>
  <official_title>Investigation on the Health Effects of Environmental and Behavioral Factors on Embryonic Development and Pregnancy Based on Internal and External Exposure Monitoring</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nanjing Jinling Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Peking University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sun Yat-sen University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shandong University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Zunyi Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Zhejiang University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Huazhong University of Science and Technology</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Nanjing Jinling Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Environmental Factors and Embryonic Development Project was set up to investigate
      environmental exposures and behavioral factors responsible for embryonic dysplasia and
      gestational complications in pregnant women.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Environmental Factors and Embryonic Development Project is about to recruit pregnant
      women from 16 cities, including Beijing, Guangzhou, Jinan, Nanjing, Hangzhou, Wuhan, Zunyi,
      Xiangyang, Nantong, Suizhou, Huangshi, Changzhou, Suqian, Shiyan, Xiaogan, and Huanggang. The
      project plans to recruit 6000-12000 participants in each city. Biological samples,
      questionnaires and data for embryonic dysplasia and gestational complications of pregnant
      women will be collected. The study includes four stages. In the first stage, the
      investigators will identify external environmental factors and behavioral factors that are
      associated with embryonic dysplasia and gestational complications in pregnant women based on
      external exposure monitoring strategies. In the second and third stages, the investigators
      will conduct several nested case-control studies based on our prospective cohort. Internal
      exposure monitoring will be applied to identify environmental endocrine disruptors which are
      associated with embryonic dysplasia and gestational complications in pregnant women in the
      second stage. In the third stage, the investigators will conduct genome-wide association
      study (GWAS) to screen susceptible genes or polymorphisms that are associated with embryonic
      dysplasia and gestational complications in pregnant women, identify any gene-environmental
      interactions with reference to the findings of the 1st and 2nd stages, and finally establish
      a comprehensive disease risk prediction model. In the fourth stage, the investigators will
      build animal models in order to identify the mechanisms how high-risk environmental exposures
      or behavioral factors as identified in the above stages may lead to embryonic dysplasia and
      gestational complications in pregnant women. The research team of the 16 cities are from
      Peking University (Beijing), Sun Yat-sen University (Guangzhou), Shandong University (Jinan),
      Chinese People's Liberation Army Eastern Theater General Hospital (Nanjing, Nantong,
      Changzhou, and Suqian), Zhejiang University (Hangzhou), Huazhong University of Science and
      Technology (Wuhan, Xiangyang, Suizhou, Huangshi, Shiyan, Xiaogan, and Huanggang), Zunyi
      Medical University (Zunyi), respectively. The core members of each research team are composed
      of experts from different disciplines in the field of public health.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 12, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of spontaneous abortion</measure>
    <time_frame>up to 28 gestational weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence of fetal death/stillbirth</measure>
    <time_frame>after 20 gestational weeks to delivery</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence of birth defects</measure>
    <time_frame>Delivery</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence of low birth weight</measure>
    <time_frame>Delivery</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence of preterm birth</measure>
    <time_frame>Delivery</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence of pregnancy with heart disease</measure>
    <time_frame>During pregnancy (up to 10 months)</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence of pregnancy with hyperthyroidism</measure>
    <time_frame>During pregnancy (up to 10 months)</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence of gestational diabetes</measure>
    <time_frame>During pregnancy (up to 10 months)</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence of gestational hypertension</measure>
    <time_frame>During pregnancy (up to 10 months)</time_frame>
  </primary_outcome>
  <number_of_groups>16</number_of_groups>
  <enrollment type="Anticipated">100000</enrollment>
  <condition>Spontaneous Abortion</condition>
  <condition>Fetal Death</condition>
  <condition>Stillbirth</condition>
  <condition>Birth Defects</condition>
  <condition>Preterm Birth</condition>
  <condition>Low Birth Weight</condition>
  <condition>Pregnancy With Medical Condition (Non-Specific)</condition>
  <condition>Gestational Diabetes</condition>
  <condition>Gestational Hypertension</condition>
  <arm_group>
    <arm_group_label>Beijing</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Guangzhou</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Jinan</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Nanjing</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Hangzhou</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Wuhan</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Zunyi</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Xiangyang</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Nantong</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Suizhou</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Huangshi</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Changzhou</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Suqian</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Shiyan</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Xiaogan</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Huanggang</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No intervention</intervention_name>
    <description>This is a multi-city observational cohort study without intervention.</description>
    <arm_group_label>Beijing</arm_group_label>
    <arm_group_label>Changzhou</arm_group_label>
    <arm_group_label>Guangzhou</arm_group_label>
    <arm_group_label>Hangzhou</arm_group_label>
    <arm_group_label>Huanggang</arm_group_label>
    <arm_group_label>Huangshi</arm_group_label>
    <arm_group_label>Jinan</arm_group_label>
    <arm_group_label>Nanjing</arm_group_label>
    <arm_group_label>Nantong</arm_group_label>
    <arm_group_label>Shiyan</arm_group_label>
    <arm_group_label>Suizhou</arm_group_label>
    <arm_group_label>Suqian</arm_group_label>
    <arm_group_label>Wuhan</arm_group_label>
    <arm_group_label>Xiangyang</arm_group_label>
    <arm_group_label>Xiaogan</arm_group_label>
    <arm_group_label>Zunyi</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      The investigators will collect a 8 ml blood sample and a 10 ml urine sample from each
      pregnant woman at their first pregnancy examination, and a 10 ml cord blood sample at
      delivery. The blood sample will be separated into plasma/serum and white blood cells/blood
      clots shortly after collection and then stored at -80 degrees celsius. The urine sample will
      be separated into several tubes before storage at -80 degrees celsius.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Pregnant women attending their first routine antenatal examinations.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. pregnancy within 13 weeks;

          2. age between 20-45 years;

          3. natural conception;

          4. singleton pregnancy;

          5. living in the local area for one year or more.

        Exclusion Criteria:

          1. pregnant women with serious chronic diseases and infectious diseases (such as cancer,
             chronic cardiovascular and cerebrovascular diseases, chronic renal failure, HIV
             infection);

          2. have participated in other scientific research projects;

          3. refuse to participate or are unwilling to sign informed consent.;

          4. are unable to guarantee delivery in our designated hospitals.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xuejun Shang, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nanjing Jinling Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Xuejun Shang, PhD</last_name>
    <phone>025-84815775</phone>
    <email>shangxj98@163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Song Xu, PhD</last_name>
    <phone>025-80861125</phone>
    <email>pinexu@126.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Haidian Maternal and Child Healthcare Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lei Jin, PhD</last_name>
      <phone>8615510251021</phone>
      <email>jinlei@bjmu.edu.cn</email>
    </contact>
    <investigator>
      <last_name>Qi Wang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Guangdong General Hospital</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Meitan People's Hospital</name>
      <address>
        <city>Zunyi</city>
        <state>Guizhou</state>
        <country>China</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Renhuai Hospital of Traditional Chinese Medicine</name>
      <address>
        <city>Zunyi</city>
        <state>Guizhou</state>
        <country>China</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Zunyi Medical University</name>
      <address>
        <city>Zunyi</city>
        <state>Guizhou</state>
        <country>China</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>The Second Affliated Hospital of Zunyi Medical University</name>
      <address>
        <city>Zunyi</city>
        <state>Guizhou</state>
        <country>China</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>People's Hospital of Qichun County</name>
      <address>
        <city>Huanggang</city>
        <state>Hubei</state>
        <country>China</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Huangshi Maternal and Child Healthcare Hospital</name>
      <address>
        <city>Huangshi</city>
        <state>Hubei</state>
        <country>China</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Shiyan Maternal and Child Healthcare Hospital</name>
      <address>
        <city>Shiyan</city>
        <state>Hubei</state>
        <country>China</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Maternal and Child Healthcare and Family Planning Service Center of Zengdu District</name>
      <address>
        <city>Suizhou</city>
        <state>Hubei</state>
        <country>China</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Huangpi Maternal and Child Healthcare Hospital</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <country>China</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Maternal and Child Healthcare Hospital of HuBei</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <country>China</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Xiangyang No. 1 People's Hospital, Hubei University of Medicine</name>
      <address>
        <city>Xiangyang</city>
        <state>Hubei</state>
        <country>China</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Anlu Maternal and Child healthcare Hospital</name>
      <address>
        <city>Xiaogan</city>
        <state>Hubei</state>
        <country>China</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Changzhou Second People's Hospital</name>
      <address>
        <city>Changzhou</city>
        <state>Jiangsu</state>
        <country>China</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Nantong Maternal and Child Healthcare Hospital</name>
      <address>
        <city>Nantong</city>
        <state>Jiangsu</state>
        <country>China</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Shuyang Hospital Affiliated to Xuzhou Medical University</name>
      <address>
        <city>Suqian</city>
        <state>Jiangsu</state>
        <country>China</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Center for Reproductive Medicine, Shandong University</name>
      <address>
        <city>Jinan</city>
        <state>Shandong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Women's Hospital, School of Medicine, Zhejiang University</name>
      <address>
        <city>Hanzhou</city>
        <state>Zhejiang</state>
        <country>China</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>November 12, 2019</study_first_submitted>
  <study_first_submitted_qc>November 28, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 2, 2019</study_first_posted>
  <last_update_submitted>November 28, 2019</last_update_submitted>
  <last_update_submitted_qc>November 28, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 2, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Nanjing Jinling Hospital</investigator_affiliation>
    <investigator_full_name>SHANG Xue-jun</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes, Gestational</mesh_term>
    <mesh_term>Premature Birth</mesh_term>
    <mesh_term>Stillbirth</mesh_term>
    <mesh_term>Hypertension, Pregnancy-Induced</mesh_term>
    <mesh_term>Abortion, Spontaneous</mesh_term>
    <mesh_term>Fetal Death</mesh_term>
    <mesh_term>Congenital Abnormalities</mesh_term>
    <mesh_term>Birth Weight</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

